Progressive Care Launches New Discharge(RX) Program to Improve Engagement Between Patients and Hospitals

MIAMI, July 10, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced the launch of its new proprietary patient engagement program, DischargeRX, designed to ensure that hospital patients are receiving the best transitional care while preserving vital hospital resources.

According to a 2017 study published in the Journal of the American Pharmacists Association, up to 26% of hospital readmissions are medication-related, creating a much-needed opportunity for a program to be created that is proactive towards patient engagement. Through Progressive Care’s wholly owned subsidiaries, DischargeRX will provide hospitals with much needed support in preventing unnecessary and costly hospital readmissions. At no cost to the hospital or patient, the program will provide access to a PharmCo representative who will offer medication-related services throughout the patient’s transitional process.

Through direct interaction between the patient and PharmCo, the company is able to understand the patient, their healthcare needs, follow-up plans and current drug regimen. After the consultation, recommendations may be made to optimize their prescription therapy through med synchronization and effective packaging options including the use of PharmCo’s SmartPack adherence solution. The patient will be given a full overview of their prescriptions, uses and best methods for staying on track with doses.

Once a patient has received a prescription from their physician, PharmCo will obtain their prescription(s) directly from the hospital and fill them, alleviating the patient of those steps. After the prescription is filled, the patient will receive a home delivery of all prescribed medications on the same day as discharge, and in some of the most effective packaging solutions available. PharmCo’s customer service staff will then monitor the patient’s progress and keep them updated on their follow-ups with Primary Care and Specialist physicians. They will also be available to provide mitigation recommendations for medication-related adverse reactions to prevent short-term medication-related readmissions, as well as post-discharge medication reconciliation.

“Our new DischargeRX program hopes to provide even more patients with Progressive Care’s adherence packaging, proactive engagement model and pharmacological expertise,” said S. Parikh Mars, CEO of Progressive Care Inc. “The program’s offering also stands to benefit hospitals, helping them to gain more control over readmission risk and improve transitional care outcomes, while also providing significant savings toward preventable adherence-related healthcare spending.”

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Tory Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com